Skip to main content
Tech.euFundingExplorerBeta

RoX Health

Investor profile

Venture capital

RoX Health has backed 2 European tech companies across 2 funding rounds between 2022 and 2023, joining rounds totalling €6.5M. Most active in Software and Healthtech. Data as of Nov 2026.

Deals
2
distinct rounds
Companies
2
backed
Active span
2022–2023
2 yrs
Total round €
€6.5M
sum of rounds joined

Deals by year

distinct rounds / year
RoX Health — deals by year — interactive chart.
Data table
RoX Health — deals by year
20221
20231

Top sectors

by deals
RoX Health — top sectors — interactive chart.
Data table
RoX Health — top sectors
Software1
Healthtech1

Stages

by deals
RoX Health — stages — interactive chart.
Data table
RoX Health — stages
Other1
Seed1

Countries

by deals
RoX Health — countries — interactive chart.
Data table
RoX Health — countries
Austria1
Germany1

Co-investment network

shared rounds
Co-investment network — interactive chart.
RoX Health — 2 dealsRoX HealthAC75 Startup Accelerator — 1 shared deals · click to openAC75 Startup AcceleratorCDP Venture Capital — 1 shared deals · click to openCDP Venture CapitalCosimo Pulli — 1 shared deals · click to openCosimo PulliIkigai — 1 shared deals · click to openIkigaiLANA Ventures — 1 shared deals · click to openLANA VenturesMassMutual Ventures (MMV) — 1 shared deals · click to openMassMutual Ventures (MMV)MMC Ventures — 1 shared deals · click to openMMC VenturesMoonstone — 1 shared deals · click to openMoonstoneOHA Osnabrück Healthcare Beteiligungs — 1 shared deals · click to openOHA Osnabrück Healthcare BeteiligungsOskar Obereder — 1 shared deals · click to openOskar OberederRudolf von Plettenberg — 1 shared deals · click to openRudolf von Plettenberg

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
XUNDAustria1€6.0M
MindAheadGermany1€500k

Biggest deals

top 10 by amount
CompanyStageAmountDate
XUNDSeed€6.0M2022-09
MindAheadOther€500k2023-01
← Back to investors